A more favourable clinical course of lymphoma relapsing after high-dose therapy: evidence of tumour heterogeneity?

@article{Enblad2000AMF,
  title={A more favourable clinical course of lymphoma relapsing after high-dose therapy: evidence of tumour heterogeneity?},
  author={Gunilla Enblad and Kristina Carlson and Marie Bengtsson and Hans Hagberg},
  journal={Medical oncology},
  year={2000},
  volume={17 3},
  pages={229-32}
}
Patients with Hodgkin's disease (HD) or large cell lymphomas who relapse after conventional chemotherapy have a poor prognosis without high-dose chemotherapy and stem cell transplantation (HDCT). Patients who relapse after HDCT have an extremely poor outcome. In the present study we describe four patients with relapsed HD (n=1) and large cell lymphomas (n=3… CONTINUE READING